Pharmascience logo

Pharmascience

North America, Quebec, Canada, Montréal

Description

Pharmascience is a manufacturer of generic drugs.

Investor Profile

Pharmascience has made 5 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Post Ipo Equity (20%)
  • Series A (20%)
  • Private Equity (20%)
  • Series B (20%)
  • Series Unknown (20%)

Country Focus

  • United States (60%)
  • Canada (20%)
  • Israel (20%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Health Diagnostics
  • Life Science
  • Clinical Trials
  • Manufacturing
  • Therapeutics
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pharmascience frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Capital Point
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Athyrium Capital Management LP
North America, New York, United States, New York
Co-Investments: 1
Signet Healthcare Partners
North America, New York, United States, New York
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Inveready
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
Hildred Capital Partners
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Pharmascience?

RDD Pharma

Ofakim, HaDarom, Israel

Phase 3 and Phase 2 ongoing in lower gastrointestinal disorders

BiotechnologyPharmaceuticalTherapeutics
Series BNov 16, 2017
Amount Raised: $9,500,000
Stellar Biotechnologies

Port Hueneme Cbc Base, California, United States

Stellar Biotechnologies develops treatments for dermatological and anorectal diseases

BiotechnologyHealth DiagnosticsPharmaceutical
Post Ipo EquitySep 20, 2017
Amount Raised: $7,000,000
Edesa Biotech

Markham, Ontario, Canada

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

BiotechnologyLife Science
Series ASep 20, 2017
Amount Raised: $7,000,000
Pharmaceutics International

Hunt Valley, Maryland, United States

Pharmaceutics International operates as a science-driven contract development and manufacturing company.

Clinical TrialsHealth CareManufacturingPharmaceutical
Private EquitySep 6, 2016
Amount Raised: $93,000,000
BionPharma

Princeton, New Jersey, United States

BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.

BiotechnologyHealth CareMedicalPharmaceutical
Series UnknownFeb 9, 2015
Amount Raised: $30,668,000